Use of compounds being combined selective serotonin (5-HT) reuptake inhibitors (SSRIs) and 5-HT1A receptor agonist for the manufacture of a medicament for use in veterinary medicine for treatment of acral lick dermatitis in dogs, psychogenic alopecia in cats, feather picking in birds placed in the cage and self inflicted trauma, snappishness and weaving in horses. In particular 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl- benzofuran-5-yl)-piperazine or a physiologically acceptable salt there of and 3-{4-[4-(4-cyano-phenyl)-piperazin-1-yl ]-butyl}-1H- indole-5-carbonitrile or a physiologically acceptable salt there of .
展开▼
